Nikola Valuation

Is 1NKLA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1NKLA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 1NKLA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 1NKLA's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1NKLA?

Key metric: As 1NKLA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 1NKLA. This is calculated by dividing 1NKLA's market cap by their current revenue.
What is 1NKLA's PS Ratio?
PS Ratio1.6x
SalesUS$75.53m
Market CapUS$118.69m

Price to Sales Ratio vs Peers

How does 1NKLA's PS Ratio compare to its peers?

The above table shows the PS ratio for 1NKLA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
OMER OMER
1.6x4.1%€118.3m
TES Tesmec
0.1x7.4%€35.0m
TNX Tenax International
0.4x16.7%€9.2m
FCT Fincantieri
0.2x7.2%€1.8b
1NKLA Nikola
1.6x67.7%€118.7m

Price-To-Sales vs Peers: 1NKLA is expensive based on its Price-To-Sales Ratio (1.6x) compared to the peer average (0.6x).


Price to Sales Ratio vs Industry

How does 1NKLA's PS Ratio compare vs other companies in the IT Machinery Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
FDA Fidia
0.08xn/aUS$2.43m
No more companies available in this PS range
1NKLA 1.6xIndustry Avg. 0.7xNo. of Companies5PS00.40.81.21.62+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 1NKLA is expensive based on its Price-To-Sales Ratio (1.6x) compared to the Italian Machinery industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is 1NKLA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1NKLA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 1NKLA's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1NKLA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.78
€11.26
+531.2%
82.2%€28.16€3.75n/a6
Nov ’25€3.40
€15.94
+368.6%
58.3%€27.58€3.68n/a6
Oct ’25€4.19
€17.25
+311.8%
44.6%€27.23€9.08n/a6
Sep ’25€6.23
€17.25
+177.1%
44.6%€27.23€9.08n/a6
Aug ’25€8.43
€26.78
+217.5%
55.4%€55.40€9.23n/a6
Jul ’25€7.30
€38.90
+432.7%
62.6%€84.02€9.34n/a6
Jun ’25n/a
€39.09
0%
59.1%€82.77€13.80n/a6
May ’25n/a
€53.14
0%
43.7%€83.17€27.72n/a6
Apr ’25n/a
€53.14
0%
43.7%€83.17€27.72n/a6
Mar ’25n/a
€53.14
0%
43.7%€83.17€27.72n/a6
Feb ’25n/a
€55.13
0%
40.8%€82.70€27.57n/a6
Jan ’25n/a
€61.55
0%
53.0%€111.91€27.98n/a5
Dec ’24n/a
€61.55
0%
53.0%€111.91€27.98n/a5
Nov ’24n/a
€68.13
0%
62.4%€141.93€28.39€3.405
Oct ’24n/a
€73.60
0%
49.1%€136.31€27.26€4.195
Sep ’24n/a
€73.60
0%
49.1%€136.31€27.26€6.235
Aug ’24n/a
€76.39
0%
47.4%€136.41€27.28€8.435
Jul ’24n/a
€73.61
0%
93.5%€220.82€27.60€7.306
Jun ’24n/a
€76.19
0%
85.2%€224.57€28.07n/a7
May ’24n/a
€87.47
0%
38.3%€138.11€27.62n/a6
Apr ’24n/a
€92.19
0%
28.3%€138.29€55.31n/a6
Mar ’24n/a
€103.70
0%
30.2%€141.41€56.56n/a6
Feb ’24n/a
€147.18
0%
44.2%€275.97€82.79n/a6
Jan ’24n/a
€147.22
0%
48.0%€282.33€70.58n/a7
Dec ’23n/a
€170.22
0%
46.7%€299.28€74.82n/a8
Nov ’23n/a
€278.05
0%
23.8%€383.51€184.09n/a8

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies